0001123292-23-000059.txt : 20230516
0001123292-23-000059.hdr.sgml : 20230516
20230516090232
ACCESSION NUMBER: 0001123292-23-000059
CONFORMED SUBMISSION TYPE: 13F-HR/A
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230331
FILED AS OF DATE: 20230516
DATE AS OF CHANGE: 20230516
EFFECTIVENESS DATE: 20230516
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athyrium Capital Management, LP
CENTRAL INDEX KEY: 0001728001
IRS NUMBER: 263965190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18509
FILM NUMBER: 23925715
BUSINESS ADDRESS:
STREET 1: 505 FIFTH AVENUE, FLOOR 18
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-402-6925
MAIL ADDRESS:
STREET 1: 505 FIFTH AVENUE, FLOOR 18
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR/A
1
primary_doc.xml
X0202
13F-HR/A
LIVE
0001728001
XXXXXXXX
03-31-2023
03-31-2023
true
1
RESTATEMENT
Athyrium Capital Management, LP
505 Fifth Avenue, Floor 18
New York
NY
10017
13F HOLDINGS REPORT
028-18509
000161528
801-73737
N
Andrew Hyman
Chief Operating Officer and General Counsel
212-402-6925
/s/ Andrew Hyman
New York
NY
05-16-2023
0
8
279118575
INFORMATION TABLE
2
informationtable.xml
Biora Inc.
COM
74319F305
4693712
1694481
SH
SOLE
1694481
0
0
Biora Inc.
Note 7.250% 12/0
74319FAB3
58075575
103500000
PRN
SOLE
0
0
103500000
Amryt Pharma PLC
Sponsored ADS
03217L106
129138967
8857268
SH
SOLE
8857268
0
0
RVL PHARMACEUTICALS PLC
SHS
G6S41R101
16644506
14600444
SH
SOLE
14600444
0
0
Omeros Corp
NOTE 6.250%11/1
682143AE2
11109890
11005000
PRN
SOLE
0
0
11005000
Omeros Corp
NOTE 5.250% 2/1
682143AG7
46503087
65136000
PRN
SOLE
0
0
65136000
PUMA BIOTECHNOLOGY INC
COM
74587V107
5537632
1792114
SH
SOLE
1792114
0
0
Paratek Pharmaceuticals Inc.
NOTE 4.750% 5/0
699374AB0
7415205
9000000
PRN
SOLE
0
0
9000000